An approach that could reduce the chances of drugs failing during the later stages of clinical trials has been demonstrated by a collaboration between the University of Cambridge and pharmaceutical company GlaxoSmithKline (GSK).
Lawrence King (Department of Sociology) and Piotr Ozieranski (University of Bath) discuss how EU member states use complex policy instruments to determine how much they are willing to pay the pharmaceutical industry for its products.
A new method of observing exactly what happens to drug particles as they travel from an asthma inhaler to the lungs could lead to the development of more efficient asthma treatments.
Cambridge research that has for the first time successfully grown “mini-livers” from adult mouse stem cells has won the UK’s international prize for the scientific and technological advance with the most potential to replace, reduce or refine the use of animals in science (the 3Rs).
New research shows clear association between ACE inhibitors - drugs used to treat high blood pressure and heart disease - and acute kidney injury06 Nov 2013
These and similar drugs are the second most prescribed on the NHS
Approval concludes nearly 40-year epic journey from fundamental research to discovery of an effective treatment for active relapsing multiple sclerosis
Individuals with a low risk for cocaine dependence have a differently shaped brain to those with addiction17 Jan 2013
Research provides unique insight into the often misunderstood world of addiction.